SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-102820
Filing Date
2019-04-10
Accepted
2019-04-10 16:15:33
Documents
7
Period of Report
2019-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695197d8k.htm 8-K 26048
2 EX-10.1 d695197dex101.htm EX-10.1 233404
3 EX-10.2 d695197dex102.htm EX-10.2 62189
4 EX-99.1 d695197dex991.htm EX-99.1 34648
5 GRAPHIC g695197g0410061310227.jpg GRAPHIC 1439
6 GRAPHIC g695197g0410061310367.jpg GRAPHIC 1657
7 GRAPHIC g695197img1.jpg GRAPHIC 10397
  Complete submission text file 0001193125-19-102820.txt   376671
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 19741824
SIC: 2834 Pharmaceutical Preparations